TCT 694: Acute Limb Ischemia Doubles In-Hospital Mortality Among Patients with Cardiogenic Shock: An Analysis from the Cardiogenic Shock Working Group

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Abiomed; Abbott
• Consultant Fee/Honoraria/Speaker’s Bureau - Abiomed; Abbott Vascular; Medtronic; Boston Scientific Corporation; Edwards Lifesciences; Getinge